Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study Examining Clinical Characteristics, Inflammatory Markers, Treatments and Outcomes of Patients Hospitalized for COVID-19 at the University of Michigan Healthcare System in Ann Arbor

NCT04706533 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04706533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study Examining Clinical Characteristics, Inflammatory Markers, Treatments and Outcomes of Patients Hospitalized for COVID-19 at the University of Michigan Healthcare System in Ann Arbor
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
March 23, 2020
Completion date
December 1, 2022
Enrollment
3,402 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, inflammation, kidney diseases, sars-cov infection